# Safety and Efficacy of hUC-MSC for the Treatment of Cartilage Damage in the Knee Joint

> **NCT06981741** · PHASE1,PHASE2 · RECRUITING · sponsor: **BIONCaRT GmbH** · enrollment: 55 (estimated)

## Conditions studied

- Cartilage Damage

## Interventions

- **BIOLOGICAL:** BP CC 001

## Key facts

- **NCT ID:** NCT06981741
- **Lead sponsor:** BIONCaRT GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-10
- **Primary completion:** 2027-11
- **Final completion:** 2028-11
- **Target enrollment:** 55 (ESTIMATED)
- **Last updated:** 2026-01-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06981741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06981741, "Safety and Efficacy of hUC-MSC for the Treatment of Cartilage Damage in the Knee Joint". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT06981741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*